Fujifilm Unit to Reserve Capacity for Coronavirus Therapy Project
Tokyo, May 1 (Jiji Press)--Japan's Fujifilm Corp. said Friday that one of its units will reserve manufacturing capacity for a coronavirus therapy development project led by the Bill and Melinda Gates Foundation.
Fujifilm Diosynth Biotechnologies will start mass production in 2021 if an effective COVID-19 therapy is successfully developed under the project.
The Fujifilm unit will allocate its large-scale biologics production facility in Denmark with six bioreactors.
The 125-million-dollar project is designed to speed up the development of a remedy for COVID-19 patients in low-income countries.
[Copyright The Jiji Press, Ltd.]